251 related articles for article (PubMed ID: 33765160)
21. Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Adhoute X; Pénaranda G; Raoul JL; Pietri O; Bronowicki JP; Castellani P; Perrier H; Monnet O; Bayle O; Oules V; Pol B; Beaurain P; Muller C; Cassagneau P; Bourlière M
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1414-1423. PubMed ID: 31045613
[TBL] [Abstract][Full Text] [Related]
22. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE).
de Baere T; Ronot M; Chung JW; Golfieri R; Kloeckner R; Park JW; Gebauer B; Kibriya N; Ananthakrishnan G; Miyayama S
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1430-1440. PubMed ID: 35978174
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
Cho Y; Lee S; Park SJ
PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
[TBL] [Abstract][Full Text] [Related]
24. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
Savic LJ; Chapiro J; Funai E; Bousabarah K; Schobert IT; Isufi E; Geschwind JH; Stark S; He P; Rudek MA; Perez Lozada JC; Ayyagari R; Pollak J; Schlachter T
Eur Radiol; 2021 May; 31(5):3002-3014. PubMed ID: 33063185
[TBL] [Abstract][Full Text] [Related]
26. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
[TBL] [Abstract][Full Text] [Related]
27. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
Liu FY; Li X; Yuan HJ; Guan Y; Wang MQ
Chin Med J (Engl); 2018 Oct; 131(20):2410-2416. PubMed ID: 30334525
[TBL] [Abstract][Full Text] [Related]
28. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW
Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach.
Malpani R; Petty CW; Yang J; Bhatt N; Zeevi T; Chockalingam V; Raju R; Petukhova-Greenstein A; Santana JG; Schlachter TR; Madoff DC; Chapiro J; Duncan J; Lin M
J Vasc Interv Radiol; 2022 Mar; 33(3):324-332.e2. PubMed ID: 34923098
[TBL] [Abstract][Full Text] [Related]
31. Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer.
Stark S; Wang C; Savic LJ; Letzen B; Schobert I; Miszczuk M; Murali N; Oestmann P; Gebauer B; Lin M; Duncan J; Schlachter T; Chapiro J
Sci Rep; 2020 Oct; 10(1):18026. PubMed ID: 33093524
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial.
Vogl TJ; Langenbach MC; Hammerstingl R; Albrecht MH; Chatterjee AR; Gruber-Rouh T
Hepatol Int; 2021 Jun; 15(3):685-694. PubMed ID: 34043158
[TBL] [Abstract][Full Text] [Related]
33. Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
Chen S; Peng Z; Zhang Y; Chen M; Li J; Guo R; Li J; Li B; Mei J; Feng S; Kuang M
Radiology; 2021 Mar; 298(3):680-692. PubMed ID: 33464183
[TBL] [Abstract][Full Text] [Related]
34. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
35. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
37. Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas.
Chan MK; Lee V; Chiang CL; Lee FA; Law G; Sin NY; Siu KL; Wong FC; Tung SY; Luk H; Blanck O
Strahlenther Onkol; 2016 Feb; 192(2):92-101. PubMed ID: 26636141
[TBL] [Abstract][Full Text] [Related]
38. Utility of the Virtual Liver Parenchymal Perfusion Area Using a Commercially Available Workstation in Transarterial Chemoembolization for Hepatocellular Carcinoma.
Kinoshita M; Takechi K; Arai Y; Shirono R; Nagao Y; Izumi S; Akagawa T; Noda S; Takao S; Ogawa C; Suwa D; Tamaki K; Uyama N; Akagawa Y; Osaki K; Ohnishi N; Tani H
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):69-77. PubMed ID: 30039504
[TBL] [Abstract][Full Text] [Related]
39. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
40. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
